HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $906,000 | +24.8% | 25,030 | 0.0% | 0.01% | +30.0% |
| Q2 2016 | $726,000 | -97.9% | 25,030 | -97.4% | 0.01% | -98.0% |
| Q1 2016 | $34,189,000 | +5.1% | 977,393 | -3.1% | 0.49% | +4.9% |
| Q4 2015 | $32,516,000 | +4.1% | 1,008,575 | +4.3% | 0.47% | +1.3% |
| Q3 2015 | $31,240,000 | -21.5% | 966,587 | +0.5% | 0.46% | -17.5% |
| Q2 2015 | $39,778,000 | -8.6% | 961,743 | -0.7% | 0.56% | -11.6% |
| Q1 2015 | $43,519,000 | +3.3% | 968,821 | -13.9% | 0.63% | -1.2% |
| Q4 2014 | $42,121,000 | +5.8% | 1,125,622 | -1.3% | 0.64% | +12.3% |
| Q3 2014 | $39,824,000 | -1.5% | 1,140,441 | -0.5% | 0.57% | +0.9% |
| Q2 2014 | $40,444,000 | +11.4% | 1,146,371 | +2.9% | 0.56% | +5.2% |
| Q1 2014 | $36,295,000 | -15.6% | 1,113,673 | +9.1% | 0.54% | -15.3% |
| Q4 2013 | $43,002,000 | +6.9% | 1,020,705 | +1.2% | 0.63% | -3.6% |
| Q3 2013 | $40,208,000 | – | 1,008,225 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |